WALL STREET JOURNAL
NATIONAL REVIEW ONLINE
THE WEEKLY STANDARD
DRUDGE REPORT
THE WASHINGTON POST
SAN DIEGO UNION-TRIBUNE
NEW YORK TIMES


*=recently updated





Matthew Hoy currently works as a metro page designer at the San Diego Union-Tribune.

The opinions presented here do not represent those of the Union-Tribune and are solely those of the author.

If you have any opinions or comments, please e-mail the author at: hoystory -at- cox -dot- net.

Dec. 7, 2001
Christian Coalition Challenged
Hoystory interviews al Qaeda
Fisking Fritz
Politicizing Prescription Drugs

RSS FEED
<< current


Amazon Honor System Click Here to Pay Learn More













A note on the Amazon ads: I've chosen to display current events titles in the Amazon box. Unfortunately, Amazon appears to promote a disproportionate number of angry-left books. I have no power over it at this time. Rest assured, I'm still a conservative.



Tuesday, February 15, 2005
Stem cell research news: Over at Tech Central Station, Michael Fumento updates us on the "surprising" news that researchers are making impressive strides in adult stem cell research, and not so much in embryonic stem cell research.


[Cardiologist Douglas] Losordo bemoans the broad-based assault by ESC researchers and the media to exaggerate the potential of ESC research while downplaying or even ignoring tremendous breakthroughs in ASC work. "I don't have any personal religious or other objections to ESC research despite the vowels in my name," he says, referring to his Italian Catholic heritage. "But as a clinical investigator I have an obligation to develop therapies which appear to be of most use to my patients."


If there was a lot of promise in embryonic stem cell research, investors would be spending money on it -- instead of the taxpayers of California.

1:51 AM

Comments: Post a Comment

Powered by Blogger Pro™